NVO earnings
Novo Nordisk (NVO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
NVO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 0.96 | 0.82 | 17.07% | $78.49B |
| Q1 2026 | May 6, 2026 | 1.04 | 0.87 | 19.54% | $96.82B |
| Q4 2025 | Feb 3, 2026 | 1.00 | 0.90 | 11.11% | $79.14B |
| Q3 2025 | Nov 5, 2025 | 1.02 | 0.77 | 32.47% | $74.98B |
| Q2 2025 | Aug 6, 2025 | 0.97 | 0.93 | 4.30% | $76.86B |
| Q1 2025 | May 7, 2025 | 0.92 | 0.92 | 0.00% | $78.09B |
| Q4 2024 | Feb 5, 2025 | 0.91 | 0.88 | 3.41% | $85.68B |
| Q3 2024 | Nov 6, 2024 | 0.88 | 0.87 | 1.38% | $71.31B |
| Q2 2024 | Aug 7, 2024 | 0.66 | 0.70 | -5.87% | $68.06B |
| Q1 2024 | May 2, 2024 | 0.82 | 0.74 | 10.53% | $65.35B |
| Q4 2023 | Jan 31, 2024 | 0.71 | 0.66 | 7.58% | $65.86B |
| Q3 2023 | Nov 2, 2023 | 0.73 | 0.69 | 5.80% | $58.73B |
| Aug 10, 2023 | 0.63 | 0.67 | -5.97% | – | |
| May 4, 2023 | 0.63 | 0.63 | 0.00% | – | |
| Feb 1, 2023 | 0.41 | 0.41 | 0.00% | – | |
| Nov 2, 2022 | 0.43 | 0.42 | 2.38% | – | |
| Aug 3, 2022 | 0.42 | 0.44 | -4.55% | – | |
| Apr 29, 2022 | 0.47 | 0.43 | 9.30% | – | |
| Feb 2, 2022 | 0.37 | 0.35 | 5.71% | – | |
| Nov 3, 2021 | 0.42 | 0.40 | 5.00% | – |
- NVO reports next on Nov 4, 2026, with EPS of 4.85 expected.
- NVO beat EPS estimates in 47 of its last 57 reports.
Updated 2026-11-02 18:32 UTC